Showing results 5 to 24 of 44
< previous
next >
Issue Date | Title | Author(s) |
2020 | Comprehensive study on electric vehicles strategy for the Indian market | P., Gouthaman; Agrawal, Nishant P. |
2015 | The consumer welfare implications of governmental policies and firm strategy in markets for medicines | Pingali, Viswanath; Chatterjee, Chirantan; Kubo, Kensuke |
2020 | COVID-19 & science, narratives & mental wellness (WIP) | P., Vaishak |
2013 | Crocin or paracetamol: what should the doctor prescribe? | Chatterjee, Chirantan; Kensuke, Kubo; Pingali, Viswanath |
7-Nov-2022 | Cross-border environmental regulation and firm labor demand | Chakraborty, Pavel; Chakrabarti, Anindya S.; Chatterjee, Chirantan |
2020 | Did COVID-19 lockdown impact consumption of risky fairness creams in India? | Kumar, Abhay; Singhania, Ankita |
2020 | Did India’s price control policy for coronary stents create unintended consequences? | Deo, Sarang; Tyagi, Hanu; Chatterjee, Chirantan; Molakapuri, Himasagar |
1-Jan-2024 | Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? New evidence from patenting data | Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan |
2020 | Fake news and misinformation | Shingi, Rashish Rajendra; Bhageria, Srishti |
2023 | Flattening the curve: COVID-19 & grand challenges for global health, innovation, and economy | - |
2019 | From courts to markets: new evidence on enforcement of pharmaceutical bans in India | Chatterjee, Chirantan; Mohapatra, D. P.; Estay, M. |
8-Jul-2019 | Future of sports and politics: historically, popular leaders have used sports to gain the legitimacy they desperately need | Chatterjee, Chirantan |
1-Dec-2022 | Generic competition and the incentives for early-stage pharmaceutical innovation | Branstetter, Lee; Chatterjee, Chirantan; Higgins, Matthew J. |
23-Mar-2022 | How do MNEs and domestic firms respond locally to a global demand shock? evidence from a pandemic | Chatterjee, Chirantan; Adbi, Arzi; Mishra, Anant |
9-Feb-2021 | How does regulation impact strategic repositioning by firms across submarkets? evidence from the Indian pharmaceutical industry | Bhaskarabhatla, Ajay; Anurag, Priyatam; Chatterjee, Chirantan; Pennings, Enrico |
2020 | Impact of non pharmaceutical (demand side) and pharmaceutical (supply side) intervention on spread of Covid-19 | Das, Manideepto; Metre, Sunita |
2020 | Impact of overseas opioid regulations on Indian opioid market | Reddy, Y. Chakradhar; Syamala, Samhitha |
2020 | Industry evolution in India’s vitamin C & D markets: evidence from 2007-2013 | Chauhan, Mayank; Joshi, Sitar |
19-Jul-2021 | Intellectual property regimes and wage inequality | Bhattacharya, Sourav; Chakraborty, Pavel; Chatterjee, Chirantan |
2020 | Interim report: GTM strategy for daytoday health for the Indian health insurance sector | Iyer, Avinash Chattanathan; Agarwal, Varun |